Improving cholesterol management in young adults
Improving Lipid Management Strategies in Young Adults
This study is looking at the best time to start cholesterol-lowering treatments for young adults aged 12 to 39 to help prevent heart disease, and it aims to create better tools to assess their risk by considering factors that affect their health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11013428 on NIH RePORTER |
What this research studies
This research focuses on understanding when to start lipid-lowering therapy in young adults to reduce the risk of atherosclerotic cardiovascular disease (ASCVD). It aims to develop better risk assessment tools that are applicable to younger populations, as current guidelines are primarily based on older adults. The study will evaluate the effectiveness of these new strategies in managing cholesterol levels and preventing heart disease in individuals aged 12 to 39. By incorporating social determinants of health, the research seeks to create a more comprehensive approach to lipid management.
Who could benefit from this research
Good fit: Ideal candidates for this research are young adults aged 12 to 39 with elevated low-density lipoprotein cholesterol (LDL-C) levels.
Not a fit: Patients who are not within the age range of 12 to 39 or those with normal LDL-C levels may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cholesterol management strategies that significantly reduce the risk of heart disease in young adults.
How similar studies have performed: Other research has shown success in developing risk assessment tools for older populations, but this approach for young adults is relatively novel.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Zhang, Yiyi — Columbia University Health Sciences
- Study coordinator: Zhang, Yiyi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.